Related Experiment Videos
Prostate brachytherapy: treatment strategies.
1Department of Urology, Mount Sinai School of Medicine, Mount Sinai Medical Center, New York, New York, USA.
The Journal of Urology
|July 20, 1999
Summary
Prostate brachytherapy offers effective treatment for localized and locally advanced prostate cancer. Stratifying patients by risk and tailoring treatment, including hormonal therapy and external beam irradiation, improves outcomes, especially in advanced cases.
Area of Science:
- Oncology
- Radiation Oncology
- Urology
Background:
- Prostate brachytherapy is a treatment option for localized and locally advanced prostate cancer.
- Patient stratification by risk factors (PSA, Gleason score, clinical stage) is crucial for treatment planning.
- Evaluating diverse patient groups is essential to understand treatment efficacy across different risk profiles.
Purpose of the Study:
- To evaluate the treatment outcomes of prostate brachytherapy in a diverse group of prostate cancer patients.
- To assess outcomes in patients with low, moderate, and high-risk prostate cancer features.
- To compare treatment strategies involving brachytherapy alone, with hormonal therapy, and with external beam irradiation.
Main Methods:
- A total of 301 patients with T1-T3 prostate cancer were treated with brachytherapy, alone or combined with hormonal therapy and/or external beam irradiation.
- Patients were stratified into low (n=109), moderate (n=152), and high-risk (n=40) groups based on PSA, Gleason score, and clinical stage.
- Follow-up included PSA monitoring, digital rectal examination, ultrasound, and prostate biopsy; failure was defined by PSA increase or local recurrence.
Main Results:
- Low-risk patients (n=109) achieved 91% freedom from PSA failure at 4 years with no urinary incontinence.
- Moderate-risk patients (n=152) showed improved outcomes with hormonal therapy (85% vs. 58% freedom from failure), particularly for Gleason score ≥7 and PSA >10 ng/mL.
- High-risk patients (n=40) had 71% freedom from biochemical failure at 3 years; no urinary incontinence was observed across all risk groups.
Conclusions:
- Prostate brachytherapy demonstrates comparable results to external beam irradiation and radical prostatectomy when stratified by disease extent.
- Tailored treatment strategies, including implant alone, implant with hormonal therapy, or implant with hormonal therapy and external beam irradiation, enhance outcomes in advanced cases.
- Brachytherapy is a safe and effective treatment option for localized and locally advanced prostate cancer across various risk stratifications.